Expert: ‘Valuable, real-world data’ combats rising prevalence of NAFLD

LONDON — Longitudinal serum alanine aminotransferase trajectories remained stable over time among a subset of patients with nonalcoholic fatty liver disease, according to research presented at the International Liver Congress.In a Healio exclusive interview, Arun J. Sanyal, MBBS, MD, director of the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, interim chair of the division of gastroenterology, hepatology and nutrition, and Z. Reno Vlahcevic professor of medicine, physiology and molecular pathology at Virginia Commonwealth University School of Medicine, highlightsRead More

Related Articles